Urogenital pathogenic bacteria

Urogenital pathogenic bacteria are a diverse group of bacterial species capable of causing infections in the urinary and genital tracts. The most prevalent pathogens include Escherichia coli and related Gram-negative bacilli (e.g., Klebsiella, Proteus, Enterobacter, Pseudomonas), as well as Gram-positive bacteria such as Staphylococcus saprophyticus, Enterococcus faecalis, Streptococcus agalactiae, and intracellular pathogens like Chlamydia trachomatis. They are implicated in urinary tract infections (including cystitis, pyelonephritis, and prostatitis), as well as sexually transmitted infections. These bacteria utilize several virulence factors for colonization and immune evasion, and their management relies on antimicrobial therapy, which is increasingly challenged by antibiotic resistance. "Urogenital pathogenic bacteria" is not a specific molecule or receptor and should not be considered a canonical drug target in molecular pharmacology. For structured drug discovery or target annotation, individual bacterial species or key molecular components (e.g., bacterial enzymes, toxins, virulence factors) should be specified instead.

Other names

Urogenital bacterial pathogensGenitourinary pathogenic bacteriaUropathogensPathogenic bacteria of the urogenital tractUrinary tract pathogens

Antibiotics target various bacterial processes: Beta-lactams inhibit cell wall synthesis; Fluoroquinolones inhibit DNA replication/repair; Macrolides, Aminoglycosides, and Tetracyclines inhibit protein synthesis; Trimethoprim-sulfamethoxazole inhibits folate synthesis.